Neurogene Inc. (NGNE)
NASDAQ: NGNE · IEX Real-Time Price · USD
30.32
-9.68 (-24.20%)
At close: Jun 18, 2024, 4:00 PM
30.60
+0.28 (0.92%)
After-hours: Jun 18, 2024, 5:34 PM EDT

Neurogene Market Cap

Neurogene has a market cap or net worth of $393.56 million as of June 18, 2024. Its market cap has increased by 1,078.33% in one year.

Market Cap
393.56M
Enterprise Value
255.09M
1-Year Change
1,078.33%
Ranking
Category
Stock Price
$30.32

Market Cap Chart

Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $393.56M, an increase of 244.93%. That is a compound annual growth rate of 12.79%.

History

DateMarket Cap% Change
Jun 17, 2024519.20M-6.08%
Jun 14, 2024552.80M1.43%
Jun 13, 2024545.00M12.93%
Jun 12, 2024482.60M-
Jun 11, 2024482.60M-0.45%
Jun 10, 2024484.80M-1.40%
Jun 7, 2024491.70M1.95%
Jun 6, 2024482.30M-0.84%
Jun 5, 2024486.40M-0.67%
Jun 4, 2024489.70M1.32%
Jun 3, 2024483.30M-0.98%
May 31, 2024488.10M10.50%
May 30, 2024441.70M2.06%
May 29, 2024432.80M5.15%
May 28, 2024411.60M-1.25%
May 24, 2024416.80M1.98%
May 23, 2024408.70M-2.83%
May 22, 2024420.60M-0.36%
May 21, 2024422.10M-4.39%
May 20, 2024441.50M2.10%
May 17, 2024432.40M-1.21%
May 16, 2024437.70M0.39%
May 15, 2024436.00M6.47%
May 14, 2024409.50M2.97%
May 13, 2024397.70M-5.74%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Lexeo Therapeutics 572.59M
Fulgent Genetics 571.25M
Erasca 563.86M
Savara 563.81M
PepGen 559.20M
Canopy Growth 551.67M
IRadimed 547.73M
Third Harmonic Bio 545.86M
Market Cap Rankings